Helps prevent and treat Vitamin B12 deficiencies
For obesity management, NICE has issued relevant guidance and technology appraisals that define NHS eligibility criteria which are distinct from marketing authorisation alone: NICE TA875 covers semaglutide (Wegovy) for managing overweight and obesity, with specific BMI and comorbidity eligibility criteria and requirements for specialist service involvement
Fei LW, Wang Y, Chen SX (2009) Improved glutathione production by gene expression in Pichia pastoris
Announced plans to build a $6.5 billion manufacturing facility in Houston, Texas, to support the production of orforglipron and other medications
The body needs this essential component for a number of processes, including the production of red blood cells, nerves, DNA, and cell growth
doi:10.1128/Spectrum.00743-21 Lee SH, Takahashi K, Hatakawa Y, Oe T